V. Grunewald et al., AMINO-ACID CHANGE IN THE EPSTEIN-BARR-VIRUS ZEBRA PROTEIN IN UNDIFFERENTIATED NASOPHARYNGEAL CARCINOMAS FROM EUROPE AND NORTH-AFRICA, International journal of cancer, 75(4), 1998, pp. 497-503
Different Epstein-Barr-virus(EBV) variants were found to be associated
with nasopharyngeal carcinoma (NPC). The type-C variant lacks the Bam
HI site between the BamHI WI and I* regions and the type-f variant ha
s an extra BamHI site in the BamHI F fragment. The BNLF1 gene (which e
ncodes the LMPI protein) from a nude-mouse-passaged CAO strain and fro
m NPC biopsies from Taiwanese patients also exhibits variations result
ing in structural and functional differences in the protein. The BZLF1
gene encodes the ZEBRA protein which triggers the EBV lytic cycle. A
difference has been observed in 8 amino acids in the ZEBRA sequence in
B95-8 (295) and P3HRI (ZP3) cell lines. EBV found in NPC biopsies and
peripheral-blood cells from Asians was predominantly of the ZP3 type
(72%), while 81% of samples from different EBV-associated diseases and
peripheral-blood cells from North Africa or Europe were of the 295 ty
pe. We found that an alanine 206 had been replaced by a serine in the
295 sequence in 72% of the NPC biopsies from European and North Africa
n patients. The Zser206 variant is found in a significantly lower perc
entage (p < 0.001) of other EBV-positive tissues from individuals in t
he same region (10-33%). In contrast, a 30-bp deletion is observed nea
r the 3' end of the LMPI gene in the majority of EBV (86%) from NPC an
d peripheral-blood cells from Asians, whereas a significantly lower pe
rcentage (p < 0.001) of NPC biopsies from European and North African p
atients (56%) have this deletion, as do lymphocytes from control indiv
iduals from the same region (36 and 55% respectively). (C) 1998 Wiley-
Liss, Inc.